Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 13Oropharyngeal Neoplasms 11Lung Neoplasms 9Carcinoma, Non-Small-Cell Lung 9Mouth Neoplasms 8Laryngeal Neoplasms 8Carcinoma 8Urinary Bladder Neoplasms 6Nasopharyngeal Carcinoma 6Hypopharyngeal Neoplasms 6Pancreatic Neoplasms 5Mesothelioma, Malignant 5Uterine Cervical Neoplasms 4Ovarian Neoplasms 4Ganglioneuroblastoma 4Gallbladder Neoplasms 4Neuroblastoma 3Medulloblastoma 3Lymphoid Interstitial Pneumonia 3Cholangiocarcinoma 3Triple Negative Breast Neoplasms 2Salivary Gland Neoplasms 2Paranasal Sinus Neoplasms 2Fallopian Tube Neoplasms 2Colorectal Neoplasms 2Carcinoma, Transitional Cell 2Adenocarcinoma of Lung 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1

Interventions

Taxes 3Paclitaxel 3Immunoglobulin G 3Disulfides 3Carboplatin 3Bevacizumab 3Gemcitabine 2adavosertib 1X-Rays 1Specimen Handling 1Platinum 1Metformin 1Mesenchymal Stem Cell Transplantation 1Magnetic Resonance Spectroscopy 1Drug Therapy 1Docetaxel 1Cisplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brenner Tumor × 1,2-diaminocyclohexaneplatinum II citrate × 1 year × Clear all
NCT00951496 2026-06-02

Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

National Cancer Institute (NCI)

Phase 3 Completed
1,560 enrolled 19 charts

Brenner Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡